Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01440452 · ClinicalTrials.gov registry record · NA

CNS Growth Factors Release and Changes in the Inflammatory Environment in Response to Electrical Stimulation in Subjects With Inflammatory Myelopathies

A NA study, sponsored by Johns Hopkins University.

Terminated
Registry status
NA
Development phase
25
Enrollment target

NCT01440452: Clinical Trial NA study, sponsored by Johns Hopkins University.

NCT01440452 is a NA study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01440452, a NA study, was terminated before completion, sponsored by Johns Hopkins University.

TERMINATED
Registry status
NA
Development phase
25 participants
Enrollment target

Study Summary

This research is being done to see how different amounts of Functional Electrical Stimulation (FES) affect cycling on factors in blood and spinal cord in people with spinal cord inflammation.

Primary Outcome

We will measure cerebrospinal fluid (CSF) concentrations of BDNF in response to FES ergometry. We will investigate whether there is a correlation between plasma and CSF BDNF concentrations.

Interventions

  • PROCEDURE Lumbar puncture
  • DEVICE FES Cycling
  • DEVICE Cycling without FES
  • BEHAVIORAL Mood assessment

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2010-11
Est. Completion 2019-07
Phase NA
Johns Hopkins University

1,448 total trials

Why NCT01440452 stopped before completion

NCT01440452 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 4 interventions - of which Lumbar puncture is the first listed.

NCT01440452 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01440452 about?

NCT01440452 is a clinical study titled "CNS Growth Factors Release and Changes in the Inflammatory Environment in Response to Electrical Stimulation in Subjects With Inflammatory Myelopathies". This research is being done to see how different amounts of Functional Electrical Stimulation (FES) affect cycling on factors in blood and spinal cord in people with spinal cord inflammation.

What is the current status of trial NCT01440452?

This trial is currently terminated. It is a NA study. The enrollment target is 25 participants. The study started on 2010-11. Estimated completion is 2019-07.

What interventions are being tested in trial NCT01440452?

The interventions under investigation include: Lumbar puncture (PROCEDURE), FES Cycling (DEVICE), Cycling without FES (DEVICE), Mood assessment (BEHAVIORAL).

Who is sponsoring clinical trial NCT01440452?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01440452's enrollment target sits among peer trials

25 1712th of 2000 higher than 265 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01440452, the US trial registry maintained by the National Library of Medicine. NCT01440452 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.